|Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy|
DJ Wile, C Toth
Diabetes care 33 (1), 156-161, 2010
|Smart watch accelerometry for analysis and diagnosis of tremor|
DJ Wile, R Ranawaya, ZHT Kiss
Journal of neuroscience methods 230, 1-4, 2014
|Behavior therapy for Tourette syndrome: a systematic review and meta-analysis|
DJ Wile, TM Pringsheim
Current treatment options in neurology 15 (4), 385-395, 2013
|An auditory neural correlate suggests a mechanism underlying holistic pitch perception|
D Wile, E Balaban
PloS one 2 (4), e369, 2007
|PBB3 imaging in Parkinsonian disorders: evidence for binding to tau and other proteins|
A Perez‐Soriano, JE Arena, K Dinelle, Q Miao, J McKenzie, N Neilson, ...
Movement Disorders 32 (7), 1016-1024, 2017
|Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies|
DJ Wile, PA Agarwal, M Schulzer, E Mak, K Dinelle, E Shahinfard, N Vafai, ...
The Lancet Neurology 16 (5), 351-359, 2017
|A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrier.|
SAJ Wile DJ, Dinelle K, Vafai N, McKenzie J, Tsui JK, Schaffer P, Ding YS ...
Movement Disorders 31 (3), 405-409, 2016
|The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study|
SY Liu, DJ Wile, JF Fu, J Valerio, E Shahinfard, S McCormick, R Mabrouk, ...
The Lancet Neurology 17 (4), 309-316, 2018
|Referrals, wait times and diagnoses at an urgent neurology clinic over 10 years|
DJ Wile, J Warner, W Murphy, AL Lafontaine, A Hanson, S Furtado
Canadian Journal of Neurological Sciences 41 (2), 260-264, 2014
|Diaschisis as the presenting feature in sporadic Creutzfeldt-Jakob disease|
D Wile, H Dhaliwal, JR Sarna, CP Molnar, JN Scott, F Costello, S Furtado, ...
JAMA neurology 70 (3), 408-409, 2013
|Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET|
JF Fu, I Klyuzhin, S Liu, E Shahinfard, N Vafai, J McKenzie, N Neilson, ...
NeuroImage: Clinical 19, 652-660, 2018
|P. 013 Needs assessment of rural telemedicine care for Parkinson disease in British Columbia|
DJ Peacock, PA Baumeister, A Monaghan, JE Siever, D Wile
Canadian Journal of Neurological Sciences 46 (s1), S17-S17, 2019
|Step on the Gas! Focal Seizures with Autonomic Features|
A Plecash, D Wile
Canadian Journal of Neurological Sciences 46 (3), 360-362, 2019
|Patterns of responses on the Montreal Cognitive Assessment in Parkinson’s Disease Associated Mild Cognitive Impairment (P1. 044)|
M Mackenzie, K Sundvick, J Cai, D Wile, A Book, ZJ Wang, M McKeown, ...
Neurology 90 (15 Supplement), P1. 044, 2018
|PET Molecular Imaging in Familial Parkinson's Disease.|
M Matarazzo, D Wile, M Mackenzie, AJ Stoessl
International review of neurobiology 142, 177-223, 2018
|The influence of LRRK2 mutations on cholinergic system in manifest and prodromal stage of Parkinson's disease: a positron emission tomography study|
SL Shu-Ying, D Wile, J Fu, J Valerio, E Shahinfard, S McCormick, ...
MOVEMENT DISORDERS 32, 2017
|Arachnoid cysts and adult onset epilepsy|
T Mackle, D Wile
CMAJ: Canadian Medical Association Journal 189 (7), E280, 2017
|Which items on the Montreal Cognitive Assessment (MoCA) in Parkinson's disease predict progression from mild cognitive impairment (MCI) to dementia?|
M Mackenzie, K Sundvick, J Cai, D Wile, M McKeown, S Appel-Cresswell
MOVEMENT DISORDERS 32, S46-S47, 2017
|PBB3 Imaging in Parkinsonian disorders: evidence for binding to abnormally aggregated proteins in addition to tau proteins|
A Perez-Soriano, JE Arena, V Sossi, K Dinelle, Q Miao, CJ McKenzie, ...
21st International Congress of Parkinson's Disease and Movement Disorders 32 …, 2017
|Reply to letter to the editor: Is there anything more to learn from SWEDD?|
DJ Wile, V Sossi, AJ Stoessl
Movement Disorders 31 (9), 1426-1428, 2016